Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 27:17:1566.
doi: 10.3332/ecancer.2023.1566. eCollection 2023.

Metastatic breast cancer in Kenya: survival, prognosis and management at a tertiary referral centre

Mwongeli Matheka  1 , Miriam Mutebi  1 , Shahin Sayed  1 , Jasmit Shah  2   3 , Asim Jamal Shaikh  4
Affiliations

Metastatic breast cancer in Kenya: survival, prognosis and management at a tertiary referral centre

Mwongeli Matheka et al. Ecancermedicalscience. .

Abstract

There has been an increase in breast cancer in Africa with up to 77% of patients diagnosed with advanced disease. However, there is little data on survival outcomes and prognostic factors affecting survival in patients with metastatic breast cancer (MBC) in Africa. The study objective was to establish the survival of patients with MBC at a single tertiary health facility, the clinical and pathological characteristics affecting survival and describe the treatment modalities used. This was a retrospective descriptive study conducted at Aga Khan University Hospital, Nairobi of patients diagnosed with MBC between 2009 and 2017. Survival data was collected on metastatic free survival, survival time between diagnosis of first metastasis and death and overall survival. Data on patient's age, menopausal status and stage at diagnosis, tumour grade, receptor status, site of metastasis and treatment given was also collected. The Kaplan-Meier Estimator was used to estimate survival. Prognostic factors for survival outcomes were analysed using univariate analysis. Standard descriptive statistics were used to describe patient characteristics. A total of 131 patients were included in the study. The median survival was 22 months. The 3 and 5-year survivals were 31.3% and 10.7%, respectively. On univariate analysis, the Luminal A molecular subtype was a significant positive prognostic factor hazard ratios (HR 0.652 95% confidence interval (CI) 0.473-0.899) while metastasis to the liver or brain were significant negative prognostic factors (HR 0.615 95% CI 0.413-0.915 and HR 0.566 95% CI 0.330-0.973, respectively). A large proportion (87.0%) received some treatment for metastatic disease. Our study concluded that survival rates for patients diagnosed with MBC were lower compared to studies from Western countries but higher than in studies from Sub-Saharan Africa. Luminal A molecular subtype was found to be a positive prognostic factor and metastasis to the liver or brain were found to be negative prognostic factors. Improved access to adequate treatment for MBC is required in the region.

Keywords: breast neoplasms; metastasis; survival rate.

PubMed Disclaimer

Conflict of interest statement

There are no competing interests for any author.

Figures

Figure 1.
Figure 1.. Survival from time from diagnosis of MBC.
Figure 2.
Figure 2.. Survival by stage at diagnosis.
See this image and copyright information in PMC

References

    1. Observatory TGC. New Global Cancer Data. 2020. [07/01/21]. [ https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf]
    1. Jedy-Agba E, McCormack V, Adebamowo C, et al. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2016;4(12):e923–e935. doi: 10.1016/S2214-109X(16)30259-5. - DOI - PMC - PubMed
    1. Ikpatt OF, Kuopio T, Collan Y. Proliferation in African breast cancer: biology and prognostication in Nigerian breast cancer material. Mod Pathol. 2002;15(8):783–789. doi: 10.1097/01.MP.0000021764.03552.BD. - DOI - PubMed
    1. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Nat Acad Sci. 2001;98(19):10869–10874. doi: 10.1073/pnas.191367098. - DOI - PMC - PubMed
    1. Dawood S, Broglio K, Ensor J, et al. Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol. 2010;21(11):2169–2174. doi: 10.1093/annonc/mdq220. - DOI - PMC - PubMed

LinkOut - more resources